Wyeth Korea releases Prevenar 13

Wyeth Korea said on June 7 it has launched its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]).

Prevenar 13 is indicated for active immunization for the prevention of invasive disease, penumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Inva...